Lv4
410 积分 2023-06-12 加入
Evaluation of the Crystallization Tendency of Commercially Available Amorphous Tacrolimus Formulations Exposed to Different Stress Conditions
4小时前
已完结
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
5天前
已关闭
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients
5天前
已完结
Practical Approaches on CD30 Detection and Reporting in Lymphoma Diagnosis
7天前
已完结
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity
12天前
已完结
Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukaemia
12天前
已完结
Pirtobrutinib in relapsed or refractory CLL and SLL
12天前
已关闭
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults
13天前
已完结
Intravenous Iron Associated Hypophosphatemia: Much More Than a Laboratory Curiosity
13天前
已关闭
BTK inhibitors: past, present, and future
14天前
已完结
皖公网安备34019202002308
